Effects of anagrelide on platelet factor 4 and vascular endothelial growth factor levels in patients with essential thrombocythemia

Br J Haematol. 2004 Sep;126(6):885-6. doi: 10.1111/j.1365-2141.2004.05139.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Blood Platelets / drug effects
  • Drug Therapy, Combination
  • Female
  • Humans
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Factor 4 / drug effects*
  • Platelet Factor 4 / metabolism
  • Quinazolines / therapeutic use*
  • Thrombocythemia, Essential / blood
  • Thrombocythemia, Essential / drug therapy*
  • Vascular Endothelial Growth Factor A / blood
  • Vascular Endothelial Growth Factor A / drug effects*

Substances

  • Platelet Aggregation Inhibitors
  • Quinazolines
  • Vascular Endothelial Growth Factor A
  • Platelet Factor 4
  • anagrelide